SCHEMBL10273437

SCHEMBL10273437

Cc1cnc(NC(=O)N(C2CCC(C)CC2)C2CCC(O)(O)CC2)s1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.48
RAB9A P51151 9/20 0.44
NPC1 O15118 7/20 0.44
GAA P10253 1/20 0.44
PKM P14618 3/20 0.43
LMNA P02545 1/20 0.43
EPHX2 P34913 1/20 0.43
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
NR3C1 P04150 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 2/20 0.38
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL998383 0.93 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL2648552 0.88 SMN1; SMN2 (0.44) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL999462 0.88 SMN1; SMN2 (0.44) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL2650060 0.87 SMN1; SMN2 (0.49) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL1002459 0.87 SMN1; SMN2 (0.49) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL1000101 0.86 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL2653739 0.86 SMN1; SMN2 (0.51) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL999351 0.85 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL998853 0.85 RAB9A (0.63) SMN1; SMN2RAB9ANPC1GAAPKM
SCHEMBL999526 0.84 RAB9A (0.50) SMN1; SMN2RAB9ANPC1GAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444397-A1 Heteroaryl-ureas and their use as glucokinase activators Novo Nordisk A/S (DK) 2012-04-25 EP disclosed